Clinical Trials: Phase II Study of Paclitaxel, Oxaliplatin, Leucovorin and 5-Fluorouracil (POLF) in Gemcitabine-Refractory Advanced Pancreatic Cancer
Sponsor and Collaborators
Seattle Cancer Treatment and Wellness Center
Contact
Ben Chue, MD
206-292-2277
Nick Chen, MD
206-292-2277
nickc@seattlecancerwellness.com
Principal Investigator
Ben Chue, MD, Seattle Cancer Treatment and Wellness Center
ClinicalTrials.gov Identifier
NCT00323583
